Canada Pension Plan Investment Board
ANIX icon

Canada Pension Plan Investment Board’s Anixa Biosciences ANIX Stock Holding History

Canada Pension Plan Investment Board’s Portfolio ANIX Stock Details ANIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$34.8K Buy
13,500
+6,000
+80% +$17.8K ﹤0.01% 1675
2025
Q4 		$23.4K Buy
+7,500
New +$30.7K ﹤0.01% 1943

Other funds holding ANIX

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LNWTC
Laird Norton Wetherby Trust Company Seattle, Washington $4.58B AUM 30.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Canada Pension Plan Investment Board's ANIX Position: Q1 2026 in Review

Canada Pension Plan Investment Board increased its Anixa Biosciences (ANIX) stake by 80% in Q1 2026, buying an estimated $17.8K and bringing the position to 13,500 shares worth $34.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1675.

Canada Pension Plan Investment Board first reported a position in ANIX in Q4 2025 and has held it in 2 quarters since. 60 funds tracked by Wall St. Rank hold ANIX as of Q1 2026.

  • Canada Pension Plan Investment Board held 13,500 shares of Anixa Biosciences worth $34.8K as of Q1 2026.
  • Canada Pension Plan Investment Board bought 6,000 Anixa Biosciences shares in Q1 2026, an estimated $17.8K.
  • Anixa Biosciences made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q1 2026, its #1675 holding.
  • Canada Pension Plan Investment Board first reported a position in Anixa Biosciences in Q4 2025 and has held it in 2 quarters since.
  • 60 funds tracked by Wall St. Rank held Anixa Biosciences as of Q1 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q1 2026, filed 15 May 2026.